This finding is in line with the literature, which points to the role of FDG PET in CBS: when due to AD pathology, hypometabolism predominates in the posterior temporoparietal areas and, when due to tau pathology, hypometabolism predominates in the thalamus and brainstem, mainly contralateral to the most affected side. The gene discussed is MAPT; the disease is Alzheimer disease.